Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Three-dimensional analysis reveals two major architectural subgroups of prostate cancer growth patterns.

Verhoef EI, van Cappellen WA, Slotman JA, Kremers GJ, Ewing-Graham PC, Houtsmuller AB, van Royen ME, van Leenders GJLH.

Mod Pathol. 2019 Jul;32(7):1032-1041. doi: 10.1038/s41379-019-0221-0. Epub 2019 Feb 8.

PMID:
30737469
2.

Three-dimensional architecture of common benign and precancerous prostate epithelial lesions.

Verhoef EI, van Cappellen WA, Slotman JA, Kremers GJ, Ewing-Graham PC, Houtsmuller AB, van Royen ME, van Leenders GJLH.

Histopathology. 2019 Jun;74(7):1036-1044. doi: 10.1111/his.13848. Epub 2019 Apr 21.

PMID:
30815904
3.

Usual and unusual histologic patterns of high Gleason score 8 to 10 adenocarcinoma of the prostate in needle biopsy tissue.

Gottipati S, Warncke J, Vollmer R, Humphrey PA.

Am J Surg Pathol. 2012 Jun;36(6):900-7. doi: 10.1097/PAS.0b013e3182495dee.

PMID:
22367295
4.

Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer.

Kweldam CF, Wildhagen MF, Steyerberg EW, Bangma CH, van der Kwast TH, van Leenders GJ.

Mod Pathol. 2015 Mar;28(3):457-64. doi: 10.1038/modpathol.2014.116. Epub 2014 Sep 5.

5.

Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy.

Choy B, Pearce SM, Anderson BB, Shalhav AL, Zagaja G, Eggener SE, Paner GP.

Am J Surg Pathol. 2016 Oct;40(10):1400-6. doi: 10.1097/PAS.0000000000000691.

PMID:
27379821
6.

The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.

Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA; Grading Committee.

Am J Surg Pathol. 2016 Feb;40(2):244-52. doi: 10.1097/PAS.0000000000000530. Review.

PMID:
26492179
7.

High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.

Zhao J, Epstein JI.

Am J Surg Pathol. 2009 Apr;33(4):583-90. doi: 10.1097/PAS.0b013e31818a5c6c.

PMID:
19033862
8.

Impact of Gleason Subtype on Prostate Cancer Detection Using Multiparametric Magnetic Resonance Imaging: Correlation with Final Histopathology.

Truong M, Hollenberg G, Weinberg E, Messing EM, Miyamoto H, Frye TP.

J Urol. 2017 Aug;198(2):316-321. doi: 10.1016/j.juro.2017.01.077. Epub 2017 Feb 3.

PMID:
28163032
9.
10.

Not all gleason pattern 4 prostate cancers are created equal: A study of latent prostatic carcinomas in a cystoprostatectomy and autopsy series.

Siadat F, Sykes J, Zlotta AR, Aldaoud N, Egawa S, Pushkar D, Kuk C, Bristow RG, Montironi R, van der Kwast T.

Prostate. 2015 Sep;75(12):1277-84. doi: 10.1002/pros.23009. Epub 2015 May 11.

PMID:
25963383
11.

Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists.

Kweldam CF, Nieboer D, Algaba F, Amin MB, Berney DM, Billis A, Bostwick DG, Bubendorf L, Cheng L, Compérat E, Delahunt B, Egevad L, Evans AJ, Hansel DE, Humphrey PA, Kristiansen G, van der Kwast TH, Magi-Galluzzi C, Montironi R, Netto GJ, Samaratunga H, Srigley JR, Tan PH, Varma M, Zhou M, van Leenders GJ.

Histopathology. 2016 Sep;69(3):441-9. doi: 10.1111/his.12976. Epub 2016 May 24.

12.

Architectural heterogeneity and cribriform pattern predict adverse clinical outcome for Gleason grade 4 prostatic adenocarcinoma.

Dong F, Yang P, Wang C, Wu S, Xiao Y, McDougal WS, Young RH, Wu CL.

Am J Surg Pathol. 2013 Dec;37(12):1855-61. doi: 10.1097/PAS.0b013e3182a02169.

PMID:
24145642
13.

Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies.

Shah RB, Magi-Galluzzi C, Han B, Zhou M.

Am J Surg Pathol. 2010 Apr;34(4):470-7. doi: 10.1097/PAS.0b013e3181cfc44b.

PMID:
20182345
14.

Clinical significance of subtypes of Gleason pattern 4 prostate cancer.

Hassan O, Matoso A.

Transl Androl Urol. 2018 Sep;7(Suppl 4):S477-S483. doi: 10.21037/tau.2018.02.06. Review.

15.

Prostate cancer grading in 2018: limitations, implementations, cribriform morphology, and biological markers.

Montironi R, Cimadamore A, Cheng L, Lopez-Beltran A, Scarpelli M.

Int J Biol Markers. 2018 Nov;33(4):331-334. doi: 10.1177/1724600818781296. Epub 2018 Jun 27.

PMID:
29945478
17.

Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort.

McKenney JK, Wei W, Hawley S, Auman H, Newcomb LF, Boyer HD, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Tretiakova MS, Vakar-Lopez F, Carroll PR, Cooperberg MR, Gleave ME, Lance RS, Lin DW, Nelson PS, Thompson IM, True LD, Feng Z, Brooks JD.

Am J Surg Pathol. 2016 Nov;40(11):1439-1456.

PMID:
27635949
18.

SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.

Pierconti F, Martini M, Cenci T, Petrone GL, Ricci R, Sacco E, Bassi PF, Larocca LM.

Prostate. 2017 May;77(6):597-603. doi: 10.1002/pros.23299. Epub 2017 Feb 1.

PMID:
28144985
19.

Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer.

Flood TA, Schieda N, Keefe DT, Breau RH, Morash C, Hogan K, Belanger EC, Mai KT, Robertson SJ.

Virchows Arch. 2016 Sep;469(3):313-9. doi: 10.1007/s00428-016-1981-2. Epub 2016 Jul 10.

PMID:
27394432
20.

Proliferation index of different Gleason pattern 4 histomorphologies and associated pattern 3 adenocarcinoma of the prostate.

Fu L, Hwang M, Adeniran AJ, Humphrey PA.

Hum Pathol. 2017 Dec;70:1-5. doi: 10.1016/j.humpath.2017.06.007. Epub 2017 Jun 27.

PMID:
28666926

Supplemental Content

Support Center